{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:35:55Z","timestamp":1793723755726,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:15:42Z","timestamp":1780557342000},"page":"1291.e1-1291.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Poor Graft Function (PGF) Following In Vivo T Cell\u2013Depleted Allogeneic Stem Cell Transplantation: The Role of Delayed Immune Reconstitution"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2158-046X","authenticated-orcid":false,"given":"Davide","family":"Murgia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2623-0415","authenticated-orcid":false,"given":"Alessandra","family":"Algarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5767-8942","authenticated-orcid":false,"given":"Chiara","family":"Pavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-5836","authenticated-orcid":false,"given":"Maria Chiara","family":"Finazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-1536","authenticated-orcid":false,"given":"Orietta","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lussana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jtct.2026.06.003_bib0001","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jtct.2026.06.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101076","article-title":"Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"60","author":"M\u00fcskens","year":"2023","journal-title":"Blood Rev"},{"issue":"12","key":"10.1016\/j.jtct.2026.06.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70059","article-title":"Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation","volume":"8","author":"M\u00fcskens","year":"2024","journal-title":"Hemasphere"},{"issue":"9","key":"10.1016\/j.jtct.2026.06.003_bib0004","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ajh.27741","article-title":"Poor engraftment after posttransplant cyclophosphamide graft-versus-host disease prophylaxis in patients with myelofibrosis","volume":"100","author":"Kim","year":"2025","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.003_bib0005","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jtct.2026.06.003_bib0006","series-title":"The EBMT Handbook","author":"Sureda","year":"2024"},{"issue":"3","key":"10.1016\/j.jtct.2026.06.003_bib0007","first-page":"151","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.06.003_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41409-023-02139-5","article-title":"Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation","volume":"59","author":"Spyridonidis","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/bloodadvances.2021004537","article-title":"Clinical features, pathophysiology, and therapy of poor graft function post\u2013allogeneic stem cell transplantation","volume":"6","author":"Prabahran","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2026.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/bmt.2016.98","article-title":"Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis","volume":"51","author":"Alchalby","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.003_bib0011","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/10428194.2021.1872072","article-title":"Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation","volume":"62","author":"Prabahran","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2026.06.003_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exphem.2017.08.003","article-title":"The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression","volume":"55","author":"Li","year":"2017","journal-title":"Exp Hematol"},{"issue":"10","key":"10.1016\/j.jtct.2026.06.003_bib0013","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbmt.2018.06.021","article-title":"Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Song","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7308","key":"10.1016\/j.jtct.2026.06.003_bib0014","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2026.06.003_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911174","article-title":"Recent advancements in poor graft function following hematopoietic stem cell transplantation","volume":"13","author":"Man","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jtct.2026.06.003_bib0016","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.bbmt.2019.05.036","article-title":"Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Zhao","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.06.003_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.10546","article-title":"Anti-erythroblast autoimmunity in early myelodysplastic syndromes","volume":"92","author":"Barcellini","year":"2007","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2026.06.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192070","article-title":"Chronic viral infections persistently alter marrow stroma and impair hematopoietic stem cell fitness","volume":"218","author":"Isringhausen","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2026.06.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107530","article-title":"Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation","volume":"143","author":"Zulch","year":"2024","journal-title":"Leuk Res"},{"issue":"18","key":"10.1016\/j.jtct.2026.06.003_bib0020","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/bloodadvances.2024013468","article-title":"Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms","volume":"8","author":"Chalandon","year":"2024","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2026.06.003_bib0021","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00277-019-03715-w","article-title":"Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation","volume":"98","author":"Sun","year":"2019","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.003_bib0022","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00277-023-05206-5","article-title":"Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide","volume":"102","author":"G\u00f3mez-Centuri\u00f3n","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.06.003_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1750093","article-title":"T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function","volume":"17","author":"Prabahran","year":"2026","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2026.06.003_bib0024","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.06.003_bib0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3324\/haematol.2024.285921","article-title":"Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study","volume":"110","author":"Kerbauy","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.06.003_bib0026","article-title":"Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant","author":"Siegel","year":"2025","journal-title":"medRxiv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:55:58Z","timestamp":1791528958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666636726004483"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.06.003","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor Graft Function (PGF) Following In Vivo T Cell\u2013Depleted Allogeneic Stem Cell Transplantation: The Role of Delayed Immune Reconstitution","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}